These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26608452)
1. Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV. Grishchuk Y; Stember KG; Matsunaga A; Olivares AM; Cruz NM; King VE; Humphrey DM; Wang SL; Muzikansky A; Betensky RA; Thoreson WB; Haider N; Slaugenhaupt SA Am J Pathol; 2016 Jan; 186(1):199-209. PubMed ID: 26608452 [TBL] [Abstract][Full Text] [Related]
2. Impaired myelination and reduced brain ferric iron in the mouse model of mucolipidosis IV. Grishchuk Y; Peña KA; Coblentz J; King VE; Humphrey DM; Wang SL; Kiselyov KI; Slaugenhaupt SA Dis Model Mech; 2015 Dec; 8(12):1591-601. PubMed ID: 26398942 [TBL] [Abstract][Full Text] [Related]
3. Association of luteal cell degeneration and progesterone deficiency with lysosomal storage disorder mucolipidosis type IV in Mcoln1-/- mouse model†. Wang Z; El Zowalaty AE; Li Y; Andersen CL; Ye X Biol Reprod; 2019 Oct; 101(4):782-790. PubMed ID: 31317194 [TBL] [Abstract][Full Text] [Related]
4. Neuropathology of the Mcoln1(-/-) knockout mouse model of mucolipidosis type IV. Micsenyi MC; Dobrenis K; Stephney G; Pickel J; Vanier MT; Slaugenhaupt SA; Walkley SU J Neuropathol Exp Neurol; 2009 Feb; 68(2):125-35. PubMed ID: 19151629 [TBL] [Abstract][Full Text] [Related]
5. Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV. Mepyans M; Andrzejczuk L; Sosa J; Smith S; Herron S; DeRosa S; Slaugenhaupt SA; Misko A; Grishchuk Y; Kiselyov K Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586947 [TBL] [Abstract][Full Text] [Related]
6. Long-term observation of a Japanese mucolipidosis IV patient with a novel homozygous p.F313del variant of MCOLN1. Hayashi T; Hosono K; Kubo A; Kurata K; Katagiri S; Mizobuchi K; Kurai M; Mamiya N; Kondo M; Tachibana T; Saitsu H; Ogata T; Nakano T; Hotta Y Am J Med Genet A; 2020 Jun; 182(6):1500-1505. PubMed ID: 32220057 [TBL] [Abstract][Full Text] [Related]
7. N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV. Boudewyn LC; Sikora J; Kuchar L; Ledvinova J; Grishchuk Y; Wang SL; Dobrenis K; Walkley SU Neurobiol Dis; 2017 Sep; 105():257-270. PubMed ID: 28610891 [TBL] [Abstract][Full Text] [Related]
8. Electroretinographical and histological study of mouse retina after optic nerve section: a comparison between wild-type and retinal degeneration 1 mice. Germain F; Istillarte M; Gómez-Vicente V; Pérez-Rico C; de la Villa P Clin Exp Ophthalmol; 2013 Aug; 41(6):593-602. PubMed ID: 23279351 [TBL] [Abstract][Full Text] [Related]
9. Neurologic, gastric, and opthalmologic pathologies in a murine model of mucolipidosis type IV. Venugopal B; Browning MF; Curcio-Morelli C; Varro A; Michaud N; Nanthakumar N; Walkley SU; Pickel J; Slaugenhaupt SA Am J Hum Genet; 2007 Nov; 81(5):1070-83. PubMed ID: 17924347 [TBL] [Abstract][Full Text] [Related]
10. Retinal function in mucolipidosis IV. Abraham FA; Brand N; Blumenthal M; Merin S Ophthalmologica; 1985; 191(4):210-4. PubMed ID: 4088609 [TBL] [Abstract][Full Text] [Related]
11. Mucolipidosis type IV in a child. Chaer L; Harissi-Dagher M; Soucy JF; Ellezam B; Hamel P J AAPOS; 2018 Dec; 22(6):469-471. PubMed ID: 30120981 [TBL] [Abstract][Full Text] [Related]
12. Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV. Li H; Pei W; Vergarajauregui S; Zerfas PM; Raben N; Burgess SM; Puertollano R Hum Mol Genet; 2017 Jul; 26(14):2701-2718. PubMed ID: 28449103 [TBL] [Abstract][Full Text] [Related]
13. MCOLN1 gene therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV. DeRosa S; Salani M; Smith S; Sangster M; Miller-Browne V; Wassmer S; Xiao R; Vandenberghe L; Slaugenhaupt S; Misko A; Grishchuk Y Hum Mol Genet; 2021 May; 30(10):908-922. PubMed ID: 33822942 [TBL] [Abstract][Full Text] [Related]
14. Characterization and expression analysis of mcoln1.1 and mcoln1.2, the putative zebrafish co-orthologs of the gene responsible for human mucolipidosis type IV. Benini A; Bozzato A; Mantovanelli S; Calvarini L; Giacopuzzi E; Bresciani R; Moleri S; Zizioli D; Beltrame M; Borsani G Int J Dev Biol; 2013; 57(1):85-93. PubMed ID: 23585356 [TBL] [Abstract][Full Text] [Related]
15. Targeted inactivation of synaptic HRG4 (UNC119) causes dysfunction in the distal photoreceptor and slow retinal degeneration, revealing a new function. Ishiba Y; Higashide T; Mori N; Kobayashi A; Kubota S; McLaren MJ; Satoh H; Wong F; Inana G Exp Eye Res; 2007 Mar; 84(3):473-85. PubMed ID: 17174953 [TBL] [Abstract][Full Text] [Related]
16. The molecular basis of mucolipidosis type IV. Slaugenhaupt SA Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810 [TBL] [Abstract][Full Text] [Related]
18. Novel compound heterozygous MCOLN1 mutations identified in a Japanese girl with severe developmental delay and thin corpus callosum. Yamaguchi N; Ban K; Suzuki A; Nakamura Y; Kato K; Muramatsu H; Okuno Y; Hattori A; Kaname T; Takahashi Y; Saitoh S Brain Dev; 2020 Mar; 42(3):298-301. PubMed ID: 31899079 [TBL] [Abstract][Full Text] [Related]
19. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration. Kjellstrom S; Bush RA; Zeng Y; Takada Y; Sieving PA Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3837-45. PubMed ID: 17652759 [TBL] [Abstract][Full Text] [Related]
20. Behavioral deficits, early gliosis, dysmyelination and synaptic dysfunction in a mouse model of mucolipidosis IV. Grishchuk Y; Sri S; Rudinskiy N; Ma W; Stember KG; Cottle MW; Sapp E; Difiglia M; Muzikansky A; Betensky RA; Wong AM; Bacskai BJ; Hyman BT; Kelleher RJ; Cooper JD; Slaugenhaupt SA Acta Neuropathol Commun; 2014 Sep; 2():133. PubMed ID: 25200117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]